Table. Characteristics of Salmonella enterica serotype Typhi isolates, France and Cameroon, 1996–2013*.
Location | 1996–1999 | 2000–2004 | 2005–2009 | 2010–2013 |
---|---|---|---|---|
France | ||||
No. isolates studied | 345 | 266 | 627 | 508 |
No. isolates acquired in Africa | 86 | 64 | 155 | 103 |
No. (%) MDR† | 0 | 7 (10.9) | 25 (16.1) | 23 (22.3) |
Country of infection for MDR isolates (no.) | Benin (3), Togo (2), Burkina-Faso (1), Cameroon (1) | Cameroon (7), Côte d’Ivoire (4), Burkina-Faso (3), Angola (2), Congo (1), Mali (1), Benin (1), Nigeria (1), Mauritania (1), Togo (1), Central African Republic (1), Guinea (1), not specified (1) | Côte d’Ivoire (7), Guinea (3), Burkina-Faso (3), Cameroon (2), Congo (1), Central African Republic (1), Niger (1), Mali (1), Nigeria (1), Chad (1), Togo (1), Algeria (1) | |
Yaoundé, Cameroon | ||||
No. isolates studied | ND | 61 | 75 | 49 |
No. (%) MDR | ND | 29 (47.5) | 50 (66.6) | 37 (75.5) |
*MDR, multidrug resistant; ND, not determined. †For isolates acquired in Africa.